Thursday, August 27, 2020 3:38:05 PM
Marijuana BOOM with legalization at US Federal level is also imminent.
KNOW WHAT YOU OWN
- Positive results from trial of RexpRx with 25 COVID-19 patients, PAOG also plans to make Coronavirus Treatment Acceleration Program (CTAP) application after entering into a CRO agreement.
- PAOG Explores Cannabis Respiratory Research Partnership in Israel.
Sandusky, Ohio--(Newsfile Corp. - August 14, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company is aggressively pursuing international research partnerships to advance its cannabis respiratory treatment development.
The company recently revealed research partnership developments in Puerto Rico where Congresswoman Jenniffer González Colón and Florida Senator Marco Rubio recently introduced legislation to position Puerto Rico as a global production center of medical equipment and drugs.
Israel is recognized as one of the leading cannabis research centers in the world. Parallel to PAOG's own research on its proprietary cannabis extract for the treatment of COVID-19, a study in Israel was recently released with findings that turpentines in cannabis showed efficacy in treating COVID-19.
PAOG recently acquired the proprietary formulations derived from a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT." The formulation tradename is RespRx.
The RespRx CBD Biopharma treatment targets multiple respiratory-related diseases to include COPD and COVID-19.
A paper on the results of the study was published and well-received, given the potential impact on this large market. WHO estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025.
https://ca.finance.yahoo.com/news/paog-explores-cannabis-respiratory-research-154400137.html
https://www.goldmanresearch.com/202008131283/Opportunity-Research/under-the-radar-cbd-pharma-player-could-offer-major-upside.html
https://ca.finance.yahoo.com/quote/PAOG?p=PAOG
https://www.jpost.com/health-science/israeli-study-finds-efficacy-in-using-cannabis-terpenes-to-treat-covid-19-638198
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM